280 related articles for article (PubMed ID: 2171402)
1. Is the release of dopamine from medial prefrontal cortex modulated by presynaptic receptors? Comparison with nigrostriatal and mesolimbic terminals.
Cubeddu LX; Hoffmann IS; Talmaciu RK
Ann N Y Acad Sci; 1990; 604():452-61. PubMed ID: 2171402
[TBL] [Abstract][Full Text] [Related]
2. Sustained high release at rapid stimulation rates and reduced functional autoreceptors characterize prefrontal cortex dopamine terminals.
Hoffmann IS; Talmaciu RK; Ferro CP; Cubeddu LX
J Pharmacol Exp Ther; 1988 Jun; 245(3):761-72. PubMed ID: 3385641
[TBL] [Abstract][Full Text] [Related]
3. Behavior of mesocortical dopamine terminals during single and repetitive stimulation: comparison with nigrostriatal neurons.
Agneter E; Hoffmann IS; Singer EA; Cubeddu LX
J Pharmacol Exp Ther; 1994 May; 269(2):470-6. PubMed ID: 8182513
[TBL] [Abstract][Full Text] [Related]
4. Comparative dopamine-cholinergic mechanisms in the olfactory tubercle and the striatum: effects of metoclopramide.
Suarez-Roca H; Lovenberg T; Cubeddu LX
J Pharmacol Exp Ther; 1987 Dec; 243(3):840-51. PubMed ID: 3320346
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of phorbol ester on prefrontal cortex and striatal dopamine terminals: dependence on rate and duration of stimulation.
Talmaciu RK; Hoffmann IS; Cubeddu LX
J Pharmacol Exp Ther; 1989 Dec; 251(3):1160-5. PubMed ID: 2557413
[TBL] [Abstract][Full Text] [Related]
6. Clozapine, haloperidol, and the D4 antagonist PNU-101387G: in vivo effects on mesocortical, mesolimbic, and nigrostriatal dopamine and serotonin release.
Broderick PA; Piercey MF
J Neural Transm (Vienna); 1998; 105(6-7):749-67. PubMed ID: 9826116
[TBL] [Abstract][Full Text] [Related]
7. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
Wachtel SR; Hu XT; Galloway MP; White FJ
Synapse; 1989; 4(4):327-46. PubMed ID: 2532422
[TBL] [Abstract][Full Text] [Related]
8. Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: II. Both D2 and "silent" D3 autoreceptors control synthesis and release in mesolimbic, mesocortical and nigrostriatal pathways.
Gobert A; Rivet JM; Audinot V; Cistarelli L; Spedding M; Vian J; Peglion JL; Millan MJ
J Pharmacol Exp Ther; 1995 Nov; 275(2):899-913. PubMed ID: 7473181
[TBL] [Abstract][Full Text] [Related]
9. Phorbol esters and D2-dopamine receptors.
Cubeddu LX; Lovenberg TW; Hoffman IS; Talmaciu RK
J Pharmacol Exp Ther; 1989 Nov; 251(2):687-93. PubMed ID: 2530340
[TBL] [Abstract][Full Text] [Related]
10. Comparative localization of neurotensin receptors on nigrostriatal and mesolimbic dopaminergic terminals.
Quirion R; Chiueh CC; Everist HD; Pert A
Brain Res; 1985 Feb; 327(1-2):385-9. PubMed ID: 2985182
[TBL] [Abstract][Full Text] [Related]
11. Dopamine autoreceptors modulate dopamine release from the prefrontal cortex.
Talmaciu RK; Hoffmann IS; Cubeddu LX
J Neurochem; 1986 Sep; 47(3):865-70. PubMed ID: 3734802
[TBL] [Abstract][Full Text] [Related]
12. Substance P and neurokinin A regulate by different mechanisms dopamine release from dendrites and nerve terminals of the nigrostriatal dopaminergic neurons.
Baruch P; Artaud F; Godeheu G; Barbeito L; Glowinski J; Chéramy A
Neuroscience; 1988 Jun; 25(3):889-98. PubMed ID: 2457187
[TBL] [Abstract][Full Text] [Related]
13. Presynaptic regulation of dopamine release in corpus striatum monitored in vitro in real time by fast cyclic voltammetry.
Palij P; Bull DR; Sheehan MJ; Millar J; Stamford J; Kruk ZL; Humphrey PP
Brain Res; 1990 Feb; 509(1):172-4. PubMed ID: 2137719
[TBL] [Abstract][Full Text] [Related]
14. Differential autoreceptor control of somatodendritic and axon terminal dopamine release in substantia nigra, ventral tegmental area, and striatum.
Cragg SJ; Greenfield SA
J Neurosci; 1997 Aug; 17(15):5738-46. PubMed ID: 9221772
[TBL] [Abstract][Full Text] [Related]
15. Native human neocortex release-regulating dopamine D2 type autoreceptors are dopamine D2 subtype.
Fedele E; Fontana G; Munari C; Cossu M; Raiteri M
Eur J Neurosci; 1999 Jul; 11(7):2351-8. PubMed ID: 10383624
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology of mesocortical dopamine neurons.
Bannon MJ; Roth RH
Pharmacol Rev; 1983 Mar; 35(1):53-68. PubMed ID: 6138783
[TBL] [Abstract][Full Text] [Related]
17. Properties of 3,4-diaminopyridine-evoked dopamine and acetylcholine release in rabbit caudate nucleus slices: involvement of facilitatory adenosine A2 receptors or nitric oxide?
Ries V; Hertting G; Jackisch R
Brain Res; 1996 Dec; 743(1-2):303-14. PubMed ID: 9017259
[TBL] [Abstract][Full Text] [Related]
18. D
López-Ramírez G; Sánchez-Zavaleta R; Ávalos-Fuentes A; José Sierra J; Paz-Bermúdez F; Leyva-Gómez G; Segovia Vila J; Cortés H; Florán B
Synapse; 2020 Mar; 74(3):e22139. PubMed ID: 31610050
[TBL] [Abstract][Full Text] [Related]
19. Regulation of dopamine synthesis in the medial prefrontal cortex: studies in brain slices.
Wolf ME; Galloway MP; Roth RH
J Pharmacol Exp Ther; 1986 Mar; 236(3):699-707. PubMed ID: 2869140
[TBL] [Abstract][Full Text] [Related]
20. Interactions between endogenous dopamine and dopamine agonists at release modulatory receptors: multiple effects of neuronal uptake inhibitors on transmitter release.
Hoffmann IS; Talmaciu RK; Cubeddu LX
J Pharmacol Exp Ther; 1986 Aug; 238(2):437-46. PubMed ID: 2942676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
